AzurRx BioPharma Announces Poster Presentation at the Americas Hepato-Pancreato-Biliary Association 2019 Annual Meeting

    NEXT STORY
    Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18
    PREV STORY
    Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock

    author_avatar
    NASDAQ Market News

    Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug “SyB P-1501”

    TOKYO, June 13, 2016 (GLOBE NEWSWIRE) -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) announced ...

    author_avatar
    NASDAQ Market News

    Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

    author_avatar
    NASDAQ Market News